Phillip G. Febbo - 06 Mar 2026 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Issuer symbol
VCYT
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 17:10:19 UTC
Previous filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Febbo Phillip G. Chief Scientific & Med Officer 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO /s/ Jonathan Wygant, as attorney-in-fact 10 Mar 2026 0001649245

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award +29,603 +25% $0.000000* 146,949 06 Mar 2026 Direct F1
transaction VCYT Common Stock Award +6,578 +4.5% $0.000000* 153,527 06 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.
F2 Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date.